Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G Concentrix Corp Filed by: Kopernik Global Investors, LLC

August 14, 2026 12:48 PM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Based on 61,018,350 common shares outstanding as of May 31, 2026, as set forth in the Issuer's Form10-Q filed with the Securities and Exchange Commission on July 2, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: Based on 61,018,350 common shares outstanding as of May 31, 2026, as set forth in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on July 2, 2026.


SCHEDULE 13G



Kopernik Global Investors, LLC
Signature:/s/Sarah L. Bertrand
Name/Title:Sarah L. Bertrand/General Counsel and Chief Compliance Officer
Date:08/14/2026
David B. Iben
Signature:/s/ David B. Iben by Sarah L. Bertrand, power of attorney
Name/Title:David B. Iben by Sarah L. Bertrand, power of attorney
Date:08/14/2026
Exhibit Information

99.1 Joint Filing Agreement, dated August 14, 2026, by and between Kopernik Global Investors, LLC and David B. Iben. 99.2 Power of Attorney appointing Sarah L. Bertrand, dated October 25, 2024, signed by David B. Iben.

ATTACHMENTS / EXHIBITS

c117468_ex99-1.htm

c117468_ex99-2.htm

Categories

SEC Filings